verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: preferred pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler preferred pharmaceuticals inc.
Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

verapamil hydrochloride 120 mg/1

Manufacturer
Preferred Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 68788-6328
Product ID 68788-6328_e287efc6-2c34-4d2f-b8e0-f59f3f93c99e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA090700
Listing Expiration 2026-12-31
Marketing Start 2016-10-17

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 687886328
Hyphenated Format 68788-6328

Supplemental Identifiers

RxCUI
897659
UNII
V3888OEY5R

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number ANDA090700 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 120 mg/1
source: ndc
Packaging
  • 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68788-6328-3)
  • 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68788-6328-6)
source: ndc

Packages (2)

68788-6328-3 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68788-6328-3) 68788-6328-6 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68788-6328-6)

Ingredients (1)

verapamil hydrochloride (120 mg/1)

Linked Drug Pages (1)

verapamil hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "e287efc6-2c34-4d2f-b8e0-f59f3f93c99e", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["897659"], "spl_set_id": ["d23c757d-39f8-48c3-ba63-df2cbe58c516"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68788-6328-3)", "package_ndc": "68788-6328-3", "marketing_start_date": "20161017"}, {"sample": false, "description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68788-6328-6)", "package_ndc": "68788-6328-6", "marketing_start_date": "20210928"}], "brand_name": "verapamil hydrochloride", "product_id": "68788-6328_e287efc6-2c34-4d2f-b8e0-f59f3f93c99e", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "68788-6328", "generic_name": "verapamil hydrochloride", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "verapamil hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "120 mg/1"}], "application_number": "ANDA090700", "marketing_category": "ANDA", "marketing_start_date": "20161017", "listing_expiration_date": "20261231"}